Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Boehringer Ingelheim
Moodys
Colorcon
Harvard Business School

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Pentastarch

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Pentastarch?

Pentastarch is an investigational drug.

There have been 5 clinical trials for Pentastarch. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2011.

The most common disease conditions in clinical trials are Shock, Shock, Hemorrhagic, and Acidosis, Lactic. The leading clinical trial sponsors are Sangart, Hamilton Health Sciences Corporation, and Ottawa Hospital Research Institute.

Recent Clinical Trials for Pentastarch
TitleSponsorPhase
Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock PatientsSangartPhase 2
Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock PatientsSangartPhase 2
Fluid Resuscitation in Early Septic ShockBaxter Healthcare CorporationPhase 2

See all Pentastarch clinical trials

Clinical Trial Summary for Pentastarch

Top disease conditions for Pentastarch
Top clinical trial sponsors for Pentastarch

See all Pentastarch clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Medtronic
Colorcon
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.